Moderator(s):
David Joel Cohen, Duk-Woo Park
Panelist(s):
Junya Ako, Yun-Dai Chen, Joo-Yong Hahn, Kyung Woo Park, Stefanie Schupke
Tailored Antithrombotic Strategy
- Guided vs. Potent P2Y12 Inhibitor Therapy: Updated Evidence
[Dominick J. Angiolillo]
- Tools for Guided Antithrombotic Strategies: Genotyping, Platelet Function, and Others
[Tullio Palmerini]
- Optimal Antithrombotic Therapy After PCI in Asia (Japan): Why We Are Going Our Own Way?
[Takeshi Kimura]
- Interactive Discussion With Audience Q&A
DAPT Duration Issues
- DAPT Study vs. Contemporary Trials: How Can We Reduce the Knowledge Gap?
[Robert W. Yeh]
- DAPT Duration and NOAC Selection in the Afib-PCI Patient
[Renato D. Lopes]
- Long-Term Antithrombotic Strategy in PCI and AF Patients: Insights From the AFIRE Trial
[Satoshi Yasuda]
- Interactive Discussion With Audience Q&A
